MARSHALL WACE, LLP

Position in LEGN — Legend Biotech Corp

CIK 1318757 LONDON, X0

Position in LEGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,194,055

-$11,240,362 QoQ

Shares Held

287,123

-62.0% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,749,797,393 across 275 Biotechnology names. LEGN ranks #97 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,099,318	$363,731,344
2	VRTX	Vertex Pharmaceuticals Inc / Ma	317,058	$141,579,078
3	INCY	Incyte Corp	1,253,138	$117,945,347
4	RPRX	Royalty Pharma plc	2,120,692	$101,729,594
5	RCUS	Arcus Biosciences, Inc.	3,761,437	$81,247,039
6	PTGX	Protagonist Therapeutics, Inc	628,075	$66,199,104
7	ROIV	Roivant Sciences Ltd.	2,246,943	$62,240,320
8	COGT	Cogent Biosciences, Inc.	1,600,168	$61,590,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,194,055	287,123	-62.0%	Shares	Other	2026-05-15
2025-12-31	$16,434,417	755,953	+4129.8%	Shares	Other	2026-02-13
2025-09-30	$582,805	17,872	+30.6%	Shares	Other	2025-11-13
2025-06-30	$485,609	13,683	-96.4%	Shares	Other	2025-08-13
2025-03-31	$12,895,571	380,064	+5.1%	Shares	Other	2025-05-15
2024-12-31	$11,765,226	361,562	-26.9%	Shares	Other	2025-02-13
2024-09-30	$24,090,503	494,367	+1231.6%	Shares	Other	2024-11-14
2022-12-31	$1,853,280	37,125	-71.1%	Shares	Other	2023-02-14
2022-03-31	$4,662,058	128,290	-66.8%	Shares	Other	2022-05-16
2021-12-31	$18,032,150	386,873	+1537.8%	Shares	Other	2022-02-14
2021-03-31	$685,510	23,622	+87.3%	Shares	Sole	2021-05-17
2020-06-30	$536,851	12,614	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.